Portfolio Update:
My asset allocation to equity shall go up. I shall strive to bring equity to up to 60% in coming months. Unfortunately I am not able to bet big on equity side given the run up of last few years (last one years big bet was only Nuvama). I trimmed bond portfolio wherever liquidity was available.
The older bets where I was big I was booking profits. For example: Nuvama in last update was 17% of portfolio, now its at 13%. Complete exit on Pricol led to some cash accretion as well. I allocated some of the Pricol and Nuvama money to Sandhar, and R&D bucket created in the last 2-3 months.
I do not feel I am in full control of my portfolio as I sprayed around money on R&D buckets and some shallow work (Sudarshan). I hope to streamline the portfolio over this quarter.
|
May-24 |
Apr-24 |
Feb-24 |
Jan-24 |
Aug-23 |
Nov-23 |
Total stocks |
21 |
11 |
16 |
21 |
23 |
22 |
Top 5 allocation |
62% |
69% |
55% |
46% |
42% |
48% |
Top 10 allocation |
87% |
97% |
87% |
74% |
71% |
78% |
Average holding period |
1 |
1.2 |
1.1 |
2 |
2 |
1 |
Some key actions and highlights:
Re-entered Tips Industries: I had sold Tips few months back around 310 rs. Stock made painful high of 500+. I re-entered at just below 420rs.
Rationale: Company entered into agreement with Warner at 10x of contract value vs. what they did 3.5 years ago. This is extremely powerful signal where this industry is going. In addition, mangement continues to guide 30% growth in revenues and earnings Even Saregama results and guidance was very strong, so I ramped up Saregama also a bit. Valuations is the area we need to take a call (reflects in my position size).
Star Health: Entered Star Health with an aim to ramp-up position as company delivers. Health Insurance is fastest growing segment in insurance vertical. Volume growth is driven by higher penetration, while value grows due to medical inflation cost. Combined result in 18 to 20% premium growth. Star is largest standalone health insurance (SAHI) company with market share of 50%+ in retail health among SAHIs.
UnitedHealthcare Group Inc. in US has created over 3000x wealth in last many years. https://www.google.com/finance/quote/UNH:NYSE?window=MAX
Several other SAHIs like Care, ABHL (Aditya Birla) have grown at over 30% for past several years. Hence, industry has characteristics of high growth.
Star’s expense of management (EOM) ratio is ~31%, enough of headroom vs. regulatory guideline of 35%. While many competitors are breaching 35%. Advantage Star?
Other triggers: 1. sharp price hike taken in last year will improve combined ratio. 2. Implementation of IFRS from FY26/27 will result in RoE bump up of ~3%.
Disclaimer: I am not a financial advisor and nor a SEBI registered Analyst. The content shared here is only for learning purpose. All the names mentioned here are for example purpose. I may buy more, exit or partly sell the stock/bonds without any prior intimation . Also note that I recently joined a investment advisory firm. My portfolio is not a recommendation for anyone. Some of these stocks might be in clients portfolio as well so please be aware of vested interest.